Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$16.70
-$0.42 (-2.5%)
Closing Price on November 25, 2024

TEVA Stock Chart and Intraday Price

TEVA Stock Data

Asset Type Stock
Exchange NYSE
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 5 BAZEL ST, P O B 3190, PETACH TIKVA, IL
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 15,133.36M USD
Shares Outstanding 1,120,990,000
Teva Pharmaceutical Industries Ltd is a global leader in the pharmaceutical industry, specializing in the development, manufacture, and distribution of generic and specialty medicines, as well as biopharmaceutical products. With a strong presence in North America, Europe, Israel, and beyond, Teva offers a wide range of medications, including treatments for central nervous system disorders, respiratory conditions, and cancer. The company is also known for its contributions to neurodegenerative and movement disorder treatments, with notable products like COPAXONE for multiple sclerosis and AJOVY for migraine prevention. Founded in 1901 and headquartered in Tel Aviv, Israel, Teva is committed to improving health and making quality healthcare accessible worldwide.

TEVA Articles

4 Can't Miss Stocks Highlight Monday's Top Wall Street Upgrades and Downgrades
Monday's top analyst upgrades and downgrades included Arm, General Electric, Micron Technology and Salesforce.
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: American Express, Keurig Dr Pepper, Meta, Teva Pharmaceutical and More
Friday's top analyst upgrades and downgrades included American Express, Aptiv, BorgWarner, First Horizon, Keurig Dr Pepper, Meta Platforms, MGIC Investment, Simon Property Group and Teva...
Lee Jackson
Published:

5 Well-Known Buy-Rated Stocks Under $10 Could Explode Higher in July
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with...
Lee Jackson
Published:

5 Very Well Known Buy-Rated Stocks Under $10 Could Explode Higher This Summer
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with...
Lee Jackson
Published:

Friday's Top Analyst Upgrades and Downgrades: Alcoa, Charles Schwab, IBM, Newmont, Philip Morris, Roblox, Shopify, Texas Instruments, Transocean and More
Friday's top analyst upgrades and downgrades included Alcoa, Charles Schwab, Cognizant Technology Solutions, IBM, Newmont, Okta, Philip Morris International, Roblox, Shopify, Teva Pharmaceutical...
Lee Jackson
Published:

Markets Settle Into Retail Earnings: Analysts Upgrade or Downgrade Bank of America, Nio and More
Monday’s additional top analyst upgrades and downgrades were on ASML, Bank of America, Dominion Energy, Hasbro, Nio, Occidental Petroleum, Teva Pharmaceutical Industries and more.
Chris Lange
Published:

Friday's Top Analyst Upgrades and Downgrades: AT&T, Exxon Mobil, Hasbro, Moderna, Snap, Under Armour and More
Friday's top analyst upgrades and downgrades included AT&T, Exxon Mobil, Hasbro, Juniper Networks, Moderna, Palo Alto Networks, Snap, Teva Pharmaceutical, Under Armour and Zscaler.
Chris Lange
Published:

Huge July Employment Report: Analysts Upgrade or Downgrade Duke Energy, Paramount, Teva Pharmaceutical and More
Friday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, BioCryst Pharmaceuticals, Duke Energy, Kellogg, Paramount Global, Rhythm Pharmaceuticals and Teva...
Chris Lange
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Caterpillar, Ford, Mosaic, Phillips 66, Plug Power, Ross Stores, Uber and More
Wednesday’s top analyst upgrades and downgrades included Bluebird Bio, Caterpillar, Chesapeake Energy, Comstock Resources, Ford, Mosaic, On Semiconductor, Phillips 66, Plug Power, Ross Stores, Teva...
Lee Jackson
Published:

Waiting for the Fed to Change: Analysts Upgrade or Downgrade Best Buy, Oracle, Teva Pharma and More
Tuesday's additional top analyst upgrades and downgrades were on Adobe, AstraZeneca, Best Buy, Chemours, Oracle, Royalty Pharma, Teva Pharmaceutical and Tractor Supply.
Chris Lange
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Home Depot, Mastercard, McDonald's, Penn National Gaming, Starbucks, Take-Two Interactive and More
Tuesday's top analyst upgrades and downgrades included Home Depot, Intuitive Surgical, Mastercard, McDonald's, Monster Beverage, Penn National Gaming, Shoals Technologies, Starbucks, Take-Two...
Lee Jackson
Published:

The Fed’s Biggest Move in 20 Years, Analysts Upgrade or Downgrade Akamai, Block, Livent, Starbucks and More
Wednesday’s additional top analyst upgrades and downgrades were on Akamai, Block, Livent, Starbucks and more.
Chris Lange
Published:

Friday Analyst Upgrades and Downgrades: Carnival, Farfetch, Fortinet, Materialise, Switch Teva Pharma and More
Friday’s additional top analyst upgrades and downgrades included Carnival, Farfetch, Fortinet, Materialise, Switch Teva Pharma and more.
Chris Lange
Published:

Thursday's Top Analyst Upgrades and Downgrades: Avis Budget, Dynatrace, Norfolk Southern, Paccar, Salesforce, Sherwin-Williams, Teva Pharmaceutical and More
Thursday's top analyst upgrades and downgrades included Avis Budget, Dynatrace, Norfolk Southern, PACCAR, Salesforce.com, Sherwin-Williams, Teradyne and Teva Pharmaceutical.
Lee Jackson
Published:

Warren Buffett's 6 Worst-Performing Stocks in Q2
Six of the stocks in Berkshire Hathaway's portfolio posted losses in the second quarter. Here is how they fared.
Paul Ausick
Published: